Sam68 is a multimeric 68-kDa RNA-binding nuclear protein of unknown function that interacts with, and is tyrosine-phosphorylated by, the oncogenic protein Src during mitosis. Random homozygous knock-out (RHKO) is a retroviral-based antisense RNA strategy that can identify chromosomal genes whose functional disablement leads to reversible tumorigenic capabilities. Here we report that RHKO-induced Sam68 deficiency results in neoplastic transformation of murine NIH3T3 fibroblasts. Whereas simple haploinsufficiency of Sam68 produced by insertion mutagenesis in a single chromosomal allele did not detectably affect cell growth, reduction of Sam68 protein to <25% of the wild type level was associated with anchorage-independent growth, defective contact inhibition, and the ability to form metastatic tumors in nude mice. These properties were reversed by cessation of RHKO inactivation. Our findings, which indicate that the Sam68 protein level can prominently affect cell proliferation, implicate Sam68 function in tumorigenesis. Consistent with these results is evidence that cells undergoing mitosis show a dramatic reduction in the level of Sam68 protein.
Sam68 is a multimeric 68-kDa RNA-binding nuclear protein of unknown function that interacts with, and is tyrosine-phosphorylated by, the oncogenic protein Src during mitosis. Random homozygous knock-out (RHKO) is a retroviral-based antisense RNA strategy that can identify chromosomal genes whose functional disablement leads to reversible tumorigenic capabilities. Here we report that RHKO-induced Sam68 deficiency results in neoplastic transformation of murine NIH3T3 fibroblasts. Whereas simple haploinsufficiency of Sam68 produced by insertion mutagenesis in a single chromosomal allele did not detectably affect cell growth, reduction of Sam68 protein to <25% of the wild type level was associated with anchorage-independent growth, defective contact inhibition, and the ability to form metastatic tumors in nude mice. These properties were reversed by cessation of RHKO inactivation. Our findings, which indicate that the Sam68 protein level can prominently affect cell proliferation, implicate Sam68 function in tumorigenesis. Consistent with these results is evidence that cells undergoing mitosis show a dramatic reduction in the level of Sam68 protein.
Sam68 (Src-associated in mitosis) is a complex 68-kDa protein discovered initially by its ability to associate with, and be tyrosine-phosphorylated by, Src specifically during mitosis (1) (2) (3) . Sam68 can interact with the Src homology domains SH2 and SH3 of a number of proteins that affect cell growth and differentiation, including other Src family tyrosine kinases (4), Cdc2 (5), p120GAP (6), Grb2 (7, 8) , phospholipase C␥-1 (7, 9) , Nck (10), Itk/Tsk (11), the poliovirus RNA-dependent RNA polymerase 3D (12) , and the insulin receptor (13) . Interestingly, Sam68 can also serve as a functional homolog of the human immunodeficiency virus Rev protein (14) .
Sam68 is a member of the STAR (signal transduction and activation of RNA) family of RNA-associated proteins essential for normal development (15) . Its KH (hnRNPK homology) domain (16) , an RNA-binding motif conserved in proteins that interact with RNA as oligomers (17) , is embedded in a larger (ϳ200 amino acids) conserved domain, designated as GSG (GRP33, Sam68, GLD-1; see Refs. 18 and 19) that can affect protein localization (20, 21) and cell cycle progression (22) . The GSG domain is present in functionally diverse proteins that include the Caenorhabditis elegans germ line-specific tumor suppressor protein GLD-1 (18), the fragile X mental retardation gene product FMR1 (23) , and the mouse quaking gene product Qk1 (24) . While genetic studies have implicated various KH domain and GSG domain proteins in development, differentiation, myelination, and tumorigenesis, the biological functions of Sam68 itself are unknown.
Random homozygous knock-out (RHKO) 1 is a retrovirusbased antisense RNA strategy devised to identify chromosomally located genes whose inactivation leads to a defined phenotype (25, 26) . This approach to the discovery of genes having functions of particular interest uses a regulated promoter within a randomly inserted chromosomally integrated retroviral gene search vector (GSV) to produce antisense transcripts complementary to those originating in the chromosomal gene bracketing the GSV. Since these antisense transcripts are also complementary to transcripts from other copies of the gene containing the GSV, the procedure can accomplish functional homozygous gene inactivation. Use of the ␤-geo reporter gene within the GSV allows the selection of GSV integration events in transcriptionally active genes and also the monitoring of antisense effects on chromosomally initiated transcripts. The antisense promoter is activated in trans by a gene whose subsequent deletion by site-specific recombination can reverse the antisense effects.
We report here the discovery that homozygous functional inactivation of Sam68 in murine NIH3T3 fibroblasts leads to neoplastic transformation, as demonstrated by the ability of RHKO cells to reversibly form colonies in 0.5% agar and tumors in nude mice. We show that such RHKO-induced tumorigenesis is associated with Sam68 protein deficiency and also that a decrease in Sam68 protein level is a feature of cell mitosis.
were treated with 1 g/ml nocodazole (Sigma) for 12 h. Mitotic cells were collected and lysed in radioimmune precipitation buffer. After mitotic cells were removed, attached cells were also lysed for analysis. Unsynchronous cells were defined as those that were not treated with any nocodazole but were incubated for same time period in complete medium before lysis. The tyrosine kinase inhibitor, radicicol (Sigma; used at 20 g/ml), or proteasome inhibitor, LLnL (Sigma; used at 40 g/ml), was added, where indicated, together with nocodazole for 12 h prior to lysis to inhibit tyrosine phosphorylation or ubiquitin-dependent proteolysis, respectively.
Identification of Fusion Transcripts-Polyadenylated mRNA was isolated from RHKO library cells in which the transactivator gene had been removed, and a cDNA library was constructed using the Life Technologies SuperScript ® plasmid system. The first cDNA strand reaction was primed with an oligonucleotide (5Ј-GAC TAG TTC TAG ATC GCG AGC GGC CGC CCG CAT CGT AAC CGT GCA TCT-3Ј) that maps to the 5Ј region of the ␤-geo sequence. cDNAs were cloned into pCM-VSPORT3.0, and fusions derived from transcripts containing the chromosomal Sam68 and gene search sequence were identified using the Gene Trapper ® cDNA positive selection system (Life Technologies). To confirm the fusion of Sam68 and GSV transcript sequences, total RNA isolated from SK⌬T2 was subjected to reverse transcription and polymerase chain reaction (RT-PCR) using a specific forward primer for mouse Sam68 cDNA (5Ј-GTC GCT GTC GCT CCT GTT CTT CC-3Ј) and a specific reverse primer for the gene search vector (5Ј-GAT CCG CCA TGT CAC AGA TC-3Ј).
Isolation of cDNA Clones-Sam68 cDNAs were isolated by RT-PCR as described previously (26) . The Sam68-specific reverse primer was 5Ј-AGG TAC ACT GTT TAT ATT TA-3Ј, and the forward primer was 5Ј-GTC GCT GTC GCT CCT GTT CTT CC-3Ј.
Western Blot Analysis-Cells were grown to 90% confluence, and whole cell lysates were prepared in radioimmune precipitation buffer (1ϫ phosphate-buffered saline, 1% Nonidet P-40 or lgepa CA-630, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate). Fifty-g amounts of these lysates were separated by electrophoresis on 10% SDS-polyacrylamide gels and electroblotted onto nitrocellulose membranes (Micron Separations Inc.). The gels were run at 100 V for 10 h. Blots were probed with anti-Sam68 monoclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and immunoreactive bands were detected by an enhanced chemiluminescence procedure (Amersham Pharmacia Biotech). The same blots were stripped and reprobed with monoclonal antibody to ␣-tubulin (clone DM 1A; Sigma) as a loading control or with anti-c-Src (Santa Cruz Biotechnology) or anti-v-Src (Upstate Biotechnology Inc., Lake Placid, NY) monoclonal antibody. Anti-mouse IgGhorseradish peroxidase was used as the secondary antibody (Santa Cruz Biotechnology). Protein levels were determined in three independent experiments by scanning autoradiograms of Western blots with Scanmaster 3TM (Howtek), which were analyzed using the Quality One program (pdi). In Vitro Cell Proliferation-Cells were seeded at a density of 0.7 ϫ 10 5 /ml in 10-cm tissue culture dishes. The live cells were counted daily using a hemacytometer.
Southern Blot Analysis-Genomic DNA was isolated from cells by standard procedures, and 25-g samples were digested with specific restriction enzymes, subjected to electrophoresis on a 1% agarose gel, blotted onto Hybond N nylon membrane (Amersham Pharmacia Biotech), and fixed to the membrane by UV cross-linking. The blots were probed with DNA fragments labeled by the random priming method.
RESULTS

Isolation of RHKO Cells Showing Anchorage-independent
Growth and the Capacity for Tumor Formation in Nude MiceUsing methods described previously (25, 26), we generated NIH3T3 cell clones able to form colonies in 0.5% agar (Table I) , which commonly has been used to select neoplastically transformed cells (27, 28) . One of these clones (Fig. 1A, left) was expanded into a cell line designated SK. Southern blot analysis showed that SK cells contain the provirus form of the pLLGSV retroviral gene search vector (25) integrated at a single chromosomal site (Fig. 2, A and B) as well as multiple copies of pLLTX (data not shown), which carries the LAP348 transactivator gene and had been introduced by electroporation to activate the antisense promoter of pLLGSV (25) .
Antisense transcription from the pLLGSV-derived provirus into the flanking chromosomal DNA sequence was initiated by transfecting SK cells with pRSV-Cre, which leads to deletion of a DNA segment containing both LAP348 and an adjacent herpes simplex virus thymidine kinase gene (25) . Cells excising this segment were identified by their resistance to gancyclovir. Seven of 16 SK-derived gancyclovir-resistant subclones (i.e. SK⌬T) no longer produced colonies in 0.5% agar, indicating that their anchorage-independent growth capabilities were reversible, whereas none of 20 individually tested untreated SK cell subclones showed reversal of anchorage-independent growth. SK⌬T2, a randomly selected gancyclovir-resistant SK derivative whose ability to generate colonies on agar was lost after treatment with pRSV-Cre (Fig. 1A, right ; Table I ) and whose deletion of the LAP348/thymidine kinase transactivator was confirmed by Southern blot hybridization using a LAP348 probe (data not shown), was selected for further study. Coincident with removal of the transactivator, production of ␤-galactosidase from the ␤-geo reporter gene contained in the pLLGSV provirus (see Fig. 2A ) resumed, leading to dark blue staining of SK⌬T2 cells by 5-bromo-4-chloro-3-indolyl ␤-D-galactopyranoside (X-gal).
Injection of SK cells subcutaneously into four athymic "nude" mice resulted in tumors at the sites of injection in all animals receiving these cells (Fig. 1B) and pulmonary metastasis of a SK-derived tumor in one animal by the time of sacrifice. In contrast, the SK-derived SK⌬T2 cell line, which had lost the ability to grow in soft agar following excision of the transactivator, did not generate detectable tumors in any of four injected animals (Fig. 1, A and B ; Table I) .
Identification of Genes Affected by RHKO in SK Cells-To identify the chromosomally encoded transcript sequence fused to ␤-geo in the tumorigenic SK cell line, a cDNA library was constructed as described under "Experimental Procedures," using as template poly(A) ϩ RNA obtained from a pool of SKderived cells that lack the transactivator. Using a cDNA capture procedure (Gene Trapper ® ; Life Technologies) that employed an oligonucleotide sequence from the ␤-geo 5Ј-end for capture, we isolated a cDNA derived from a 484-base pair transcript segment fused in frame to the pLLGSV splice acceptor site (SA) 5Ј to ␤-geo (Fig. 2A) . The sequence of this segment (Fig. 3A) showed identity to nucleotides 1-482 of the previously reported exonic sequence of the murine Sam68 gene (7). Additionally, an RT-PCR product made using total RNA from SK⌬T2 cells as template and two sets of nested oligonucleotides corresponding to ␤-geo and the 5Ј-end coding sequence of Sam68 as primers was found by Southern blotting and sequence analysis (Fig. 3B ) to correspond to a Sam68/␤-geo fusion transcript. In this transcript, a presumed splice donor site 187 nucleotides within the Sam68 coding sequence was fused to the splice acceptor site 5Ј to ␤-geo (Fig. 3A) , consistent with previous evidence that Sam68 transcripts can undergo alternative splicing (22) . Southern blot comparison of genomic DNAs from SK cells and the parental NIH3T3 cell line using Sam68 cDNA as probe provided direct confirmation at the DNA level that SK cells contain pLLGSV inserted within the Sam68 gene (Fig. 3C) .
Using primers corresponding to the 5Ј-and 3Ј-ends of the Sam68 coding sequence and total RNA obtained from SK⌬T2 cells, we synthesized Sam68 cDNA by RT-PCR and cloned this cDNA in plasmid pCR3.1 (26) in the antisense direction behind the cytomegalovirus early gene promoter (25) . An antisense cDNA construct isolated from a randomly selected bacterial clone was introduced into naive NIH3T3 cells, yielding a heterogeneous population of stably transfected cells containing chromosomal inserts at different locations. This population contained clones capable of anchorage-independent growth in 0.5% agar (Fig. 4; and Table II) indicated that the native Sam68 protein is present in SK cells at approximately one-fourth the concentration observed for parental (NIH3T3) cells. The nontumorigenic revertant clone SK⌬T2 and four randomly selected additional clones that, like SK⌬T2, had undergone phenotypic reversion of tumorigenic capabilities following transfection by pRSV-Cre showed more than twice this level of Sam68, consistent with the observed reversal of RHKO. However, the Sam68 level in these clones remained at approximately one-half of normal, consistent with the presence of a resident pLLGSV proviral insert in one chromosomal allele (Fig. 5A and Table II ). The more rapidly migrating band detected by Sam68 antibody in both SK and SK⌬T2 cells was associated with the presence of the GSV in these cells and may represent a splice variant. The irreversibility of tumorigenic capabilities in several other clones following introduction of Cre and a consequent increase in Sam68 suggests that neoplastic progression (see Refs. 29 -32) had occurred in these clones during antisense-induced Sam68 deficiency. This observation is reminiscent of earlier findings showing that the reintroduction of tumor suppressor gene function into cancer cells defective in these genes may not uniformly revert phenotypic abnormalities (33) (34) (35) (36) (37) (38) (39) . The Sam68 decrease in SK cells was additionally associated with an increased rate of growth and defective contact inhibition. As shown in Fig. 5B , during 5 days of culture SK cells grew to a cell density that was twice that attained by NIH3T3 cells plated at the same initial density. SK⌬T2 cells showed growth characteristics similar to those of NIH3T3 cells.
Alteration of Sam68 Protein Level during Mitosis-During mitosis, Sam68 interacts with and is phosphorylated by the Src tyrosine kinase, which itself undergoes mitosis-related phosphorylation at specific serine and threonine residues (40) . The finding that induced Sam68 deficiency can affect cell proliferation led us to examine the Sam68 protein level during mitosis. Representative results are shown for soft agar assays evaluating anchorage-independent growth of NIH3T3 fibroblasts containing control constructs or constructs expressing Sam68 cDNA in the antisense direction. Transfected cells were selected for growth in 800 g/ml G418 for 18 days, and resistant cells were plated in 0.5% agar and incubated for 3 weeks. Magnification was ϫ 100.
The results of these experiments, which employed human glioblastoma cells, showed a dramatic decrease in Sam68 protein level in cells arrested in mitosis by treatment with nocodazole, compared with an unsynchronized actively dividing cell population (Fig. 6 ). This mitosis-associated decrease of Sam68, which Northern blot analysis showed is mediated post-transcriptionally (data not shown), was accompanied by a reciprocal increase in c-Src (Fig. 6) . However, no alteration of either the intracellular concentration or the extent of phosphorylation of c-Src was observed in the tumorigenic SK line of mouse
DISCUSSION
Our results show that Sam68 deficiency can result in reversible tumorigenesis in NIH3T3 murine fibroblasts. Reduction of Sam68 protein to ϳ25% of the wild type level was associated with colony formation in 0.5% agar, defective contact inhibition, and the ability to form metastatic tumors in nude mice. While there has been no previously reported evidence that Sam68 can modulate neoplastic transformation, the related GLD-1 protein is known to be a tumor suppressor in C. elegans (18) .
Sam68 is the only known mitotic target for the oncogenic tyrosine kinase Src, which interacts with and phophorylates Sam68 specifically during mitosis (1) (2) (3) . Although it has been speculated that Sam68 may have a role in linking the signaling pathways of Src and other Src family tyrosine kinases such as the threonine kinase, Cdc2, and the insulin receptor to downstream proteins or nuclear targets (5, 8, 13) , an effect on Srcmediated signaling has not been shown. Possible alternative biological roles for Sam68 have included the regulation of RNA metabolism or cell cycle control (1, 3, 5, 7, 10, 13, 15, 22, 41) . Consistent with the latter role is our observation that Sam68-deficient SK cells show decreased responsiveness to contact inhibition.
Earlier work has shown that a natural isoform of Sam68 deleted for 39 amino acids within the KH domain is expressed during cell growth arrest and that production of this protein by transfected constructs inhibits DNA synthesis and cyclin D1 expression (22) . Overexpression of Sam68, which had no effect on DNA synthesis per se, reversed this inhibition, suggesting that different isoforms of Sam68 protein may compete for common pathways in the regulation of cell growth (22) . Transcripts consistent with alternative splicing of Sam68 pre-mRNA at additional sites were also observed in our experiments (data not shown). Whether the antisense RNA produced by RHKO alters the balance of Sam68 isoforms by affecting pre-mRNA splicing (e.g. see Refs. [42] [43] [44] [45] is not known.
Decreased Sam68 protein in the absence of any charge in the steady state level of Sam68 mRNA was also observed in human glioblastoma cells arrested in mitosis by nocodazole. Two proteasome inhibitors (LLnL and MG-132) and two inhibitors of tyrosine phosphorylation (radicicol and p60 v-src 137-15) had no affect on mitotic regulation of Sam68. Our findings together with those of other published reports (1, (3) (4) (5) are consistent with the hypothesis that the Sam68 protein can function as a growth inhibitor/tumor suppressor that acts as a downstream substrate of oncogenic tyrosine kinases. However, we have been unable to detect an effect of Sam68 overexpression on v-Src-induced focus formation or on reversion of v-Src-induced transformation.
While elevation of Sam68 protein from ϳ25% of normal (i.e. the level observed during activation of the antisense promoter that had been inserted in the Sam68 gene) to ϳ50% of the wild FIG. 5 . A, Western blot analysis of the effect of RHKO on Sam68 protein. Total cell lysates from SK, SK⌬T2, and NIH3T3 cells (50 g in each lane) were separated by electrophoresis on a 10% SDS-polyacrylamide gel. Anti-Sam68 monoclonal antibody was used to detect the protein levels. ␣-Tubulin detected by monoclonal antibody was used as a loading control. The gel here is one of three separate assays showing similar results. B, growth curves of SK, SK⌬T2, and NIH3T3 cells. Cells were plated at an initial cell density of 0.7 ϫ 10 5 /ml, and cell number was determined daily as described under "Experimental Procedures." There is evidence that the activity of proteins that suppress cell proliferation can be abrogated by a multiplicity of mechanisms. Among these are mutation or deletion of corresponding DNA (48 -52) , sequestration of the suppressor protein by viral or cellular proteins (53, 54) , selective proteolysis (55) (56) (57) (58) (59) (60) , and aberrant splicing (61) . Whereas genomic mutations that lead to absolute loss of function traditionally have provided a definition for and a basis for the discovery of tumor suppressor genes (e.g. Refs. [62] [63] [64] [65] , there is increasing evidence that the actions of tumor suppressor proteins can be highly dose-dependent. Venkatachalam et al. (66) have demonstrated that homozygous loss of both p53 alleles is not a prerequisite for tumor formation and that simple reduction in p53 levels may be sufficient to promote tumorigenesis. Transforming growth factor-␤1 also has been reported to show true haploinsufficiency in its ability to protect against cancer development (67) . Additionally, a decrease in Bax expression can accelerate tumor progression (68) , and reduction of the cellular concentration of p27 kip1 to 50% of normal level can lead to increased tumorigenesis in mice following radiation (69) ; interestingly, the cancer cells so generated have the same amount of p27 kip1 protein as nontumor tissue from tumor-bearing mice (69) . Recent data indicate that loss of one copy of sno also increases susceptibility to tumorigenesis in mice (70) . The RHKO strategy used to discover the role of Sam68 in suppressing neoplastic transformation of NIH3T3 cells selects for antisense vector insertions at sites that yield phenotypic effects; since such effects may not require total ablation of protein, RHKO may especially facilitate the identification of tumor suppressor loci whose abnormal regulation leads to neoplasia. 
